Universal Vision Biotechnology Co., Ltd. (TPEX: 3218)

Universal Vision Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	503.91	1,063	703.02	534.19	616	372.14
Short-Term Investments	282.64	578.36	576.62	505.81	461.75	338.97
Trading Asset Securities	1,284	-	-	-	-	-
Cash & Short-Term Investments	2,071	1,641	1,280	1,040	1,078	711.11
Cash Growth	47.22%	28.23%	23.04%	-3.50%	51.56%	-13.25%
Accounts Receivable	539.52	584.25	581.82	534.93	377.13	342.14
Other Receivables	12.13	2.17	3.37	11.31	33.8	42.86
Receivables	551.65	586.42	585.18	546.25	410.92	385
Inventory	280.96	294.52	227.62	115.65	62.62	61.02
Other Current Assets	60.44	58.03	66.54	77.21	90.78	63.51
Total Current Assets	2,964	2,580	2,159	1,779	1,642	1,221
Property, Plant & Equipment	2,608	2,323	2,206	1,724	1,413	1,312
Long-Term Investments	117.01	-	-	-	-	-
Other Intangible Assets	23.19	22.98	25.91	26.57	26.52	7.25
Long-Term Deferred Tax Assets	72.53	67.25	55.91	48.31	34.47	44.59
Other Long-Term Assets	41.26	137.06	59.25	171.76	53.11	62.43
Total Assets	5,826	5,131	4,506	3,750	3,169	2,647
Accounts Payable	269.14	312.31	254.55	210.5	122.93	76.48
Accrued Expenses	223.12	226.54	210.26	170.08	128.1	78.97
Short-Term Debt	476.97	8.67	-	-	176.9	80.95
Current Portion of Long-Term Debt	-	1.3	9.17	9.03	-	-
Current Portion of Leases	177.68	155.27	141.45	130.72	108	110.22
Current Income Taxes Payable	105.2	162.57	134.37	85.7	77.44	46.16
Current Unearned Revenue	35.86	24.19	23.32	16.24	14.22	8.57
Other Current Liabilities	160.92	132.25	137.25	109.39	125.83	124.37
Total Current Liabilities	1,449	1,023	910.38	731.66	753.41	525.7
Long-Term Debt	-	-	1.32	10.33	-	-
Long-Term Leases	723.28	613.02	631.7	617.45	329.24	391.58
Long-Term Deferred Tax Liabilities	61.47	58.39	44.26	24.94	-	-
Other Long-Term Liabilities	65.52	93.12	88.8	36.78	47.04	34.55
Total Liabilities	2,299	1,788	1,676	1,421	1,130	951.83
Common Stock	847.25	847.25	799.29	761.23	761.23	761.23
Additional Paid-In Capital	381.92	381.92	381.92	381.92	381.92	381.92
Retained Earnings	2,149	1,960	1,488	1,056	779.86	462.29
Comprehensive Income & Other	9.15	-11.38	-5.04	-10.37	-9.12	-14.09
Total Common Equity	3,388	3,178	2,664	2,188	1,914	1,591
Minority Interest	138.8	165.33	165.02	140.13	125.55	103.99
Shareholders' Equity	3,526	3,343	2,829	2,328	2,039	1,695
Total Liabilities & Equity	5,826	5,131	4,506	3,750	3,169	2,647
Total Debt	1,378	778.26	783.65	767.53	614.14	582.74
Net Cash (Debt)	692.83	862.65	495.99	272.47	463.61	128.37
Net Cash Growth	16.16%	73.92%	82.03%	-41.23%	261.16%	-80.75%
Net Cash Per Share	8.16	10.16	5.85	3.21	5.46	1.51
Filing Date Shares Outstanding	84.73	84.73	84.72	84.72	84.72	84.72
Total Common Shares Outstanding	84.73	84.73	84.72	84.72	84.72	84.72
Working Capital	1,515	1,557	1,249	1,047	888.66	694.93
Book Value Per Share	39.98	37.51	31.45	25.83	22.59	18.78
Tangible Book Value	3,364	3,155	2,638	2,162	1,887	1,584
Tangible Book Value Per Share	39.71	37.23	31.14	25.52	22.28	18.70
Land	179.87	179.87	179.87	179.87	179.87	179.87
Buildings	67.11	67.11	66.76	66.76	66.65	66.54
Machinery	2,422	2,165	1,884	1,480	1,346	1,112
Construction In Progress	47.54	32.82	91.84	-	-	-
Leasehold Improvements	652.93	615.67	473.07	340.85	306.52	260.67

Source: S&P Capital IQ. Standard template. Financial Sources.